{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T19:57:27Z","timestamp":1793735847356,"version":"4.6.1"},"reference-count":200,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T00:00:00Z","timestamp":1742947200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T00:00:00Z","timestamp":1742947200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Institute of Health","award":["RF1AG059694"],"award-info":[{"award-number":["RF1AG059694"]}]},{"name":"DOD","award":["HT9425-23-1-0879"],"award-info":[{"award-number":["HT9425-23-1-0879"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Neurodegener"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Traumatic brain injury (TBI) has emerged as a significant risk factor for Alzheimer\u2019s disease (AD), a complex and devastating neurodegenerative disorder characterized by progressive cognitive decline and memory loss. Both conditions share a common feature: blood\u2012brain barrier (BBB) dysfunction, which is believed to play a pivotal role in linking TBI to the development of AD. This review delves into the intricate relationship between TBI and AD, with a focus on BBB dysfunction and its critical role in disease mechanisms and therapeutic development. We first present recent evidence from epidemiological studies highlighting the increased incidence of AD among individuals with a history of TBI, as well as pathological and animal model studies that demonstrate how TBI can accelerate AD-like pathology. Next, we explore the mechanisms by which BBB dysfunction may mediate TBI-induced AD pathology. Finally, we investigate the shared molecular pathways associated with BBB dysfunction in both TBI and AD conditions and discuss the latest findings on how targeting these pathways and employing regenerative approaches, such as stem cell therapy and pharmacological interventions, can enhance BBB function and mitigate neurodegeneration.<\/jats:p>","DOI":"10.1186\/s40035-025-00478-5","type":"journal-article","created":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T02:22:15Z","timestamp":1742955735000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Blood\u2013brain barrier disruption: a pervasive driver and mechanistic link between traumatic brain injury and Alzheimer's disease"],"prefix":"10.1186","volume":"14","author":[{"given":"Bryan","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lulin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Odette A.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2064-8467","authenticated-orcid":false,"given":"Jian","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,26]]},"reference":[{"issue":"4","key":"478_CR1","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1002\/alz.13016","volume":"19","author":"Alzheimer\u2019s Association","year":"2023","unstructured":"Alzheimer\u2019s Association. Alzheimer\u2019s disease facts and figures. Alzheimers Dement. 2023;19(4):1598\u2013695.","journal-title":"Alzheimers Dement"},{"issue":"1","key":"478_CR2","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41572-021-00269-y","volume":"7","author":"DS Knopman","year":"2021","unstructured":"Knopman DS, Amieva H, Petersen RC, Chetelat G, Holtzman DM, Hyman BT, et al. Alzheimer disease. Nat Rev Dis Primers. 2021;7(1):33.","journal-title":"Nat Rev Dis Primers"},{"issue":"5","key":"478_CR3","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.biopsych.2021.05.025","volume":"91","author":"BL Brett","year":"2022","unstructured":"Brett BL, Gardner RC, Godbout J, Dams-O\u2019Connor K, Keene CD. Traumatic brain injury and risk of neurodegenerative disorder. Biol Psychiatry. 2022;91(5):498\u2013507.","journal-title":"Biol Psychiatry"},{"issue":"11","key":"478_CR4","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1136\/jnnp-2017-317557","volume":"90","author":"NS Graham","year":"2019","unstructured":"Graham NS, Sharp DJ. Understanding neurodegeneration after traumatic brain injury: from mechanisms to clinical trials in dementia. Neurol Neurosurg Psychiatry. 2019;90(11):1221\u201333.","journal-title":"Neurol Neurosurg Psychiatry"},{"issue":"8","key":"478_CR5","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1177\/0271678X21992462","volume":"41","author":"JI Szu","year":"2021","unstructured":"Szu JI, Obenaus A. Cerebrovascular phenotypes in mouse models of Alzheimer\u2019s disease. J Cereb Blood Flow Metab. 2021;41(8):1821\u201341.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"4","key":"478_CR6","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.cell.2015.12.056","volume":"164","author":"B De Strooper","year":"2016","unstructured":"De Strooper B, Karran E. The cellular phase of Alzheimer\u2019s disease. Cell. 2016;164(4):603\u201315.","journal-title":"Cell"},{"issue":"9","key":"478_CR7","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1001\/jamaneurol.2018.0815","volume":"75","author":"DE Barnes","year":"2018","unstructured":"Barnes DE, Byers AL, Gardner RC, Seal KH, Boscardin WJ, Yaffe K. Association of mild traumatic brain injury with and without loss of consciousness with dementia in US military veterans. JAMA Neurol. 2018;75(9):1055\u201361.","journal-title":"JAMA Neurol"},{"issue":"5","key":"478_CR8","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/S2215-0366(18)30065-8","volume":"5","author":"JR Fann","year":"2018","unstructured":"Fann JR, Ribe AR, Pedersen HS, Fenger-Gron M, Christensen J, Benros ME, et al. Long-term risk of dementia among people with traumatic brain injury in Denmark: a population-based observational cohort study. Lancet Psychiatry. 2018;5(5):424\u201331.","journal-title":"Lancet Psychiatry"},{"issue":"4","key":"478_CR9","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1037\/neu0000423","volume":"32","author":"J Schaffert","year":"2018","unstructured":"Schaffert J, LoBue C, White CL, Chiang HS, Didehbani N, Lacritz L, et al. Traumatic brain injury history is associated with an earlier age of dementia onset in autopsy-confirmed Alzheimer\u2019s disease. Neuropsychology. 2018;32(4):410\u20136.","journal-title":"Neuropsychology"},{"issue":"10248","key":"478_CR10","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/S0140-6736(20)30367-6","volume":"396","author":"G Livingston","year":"2020","unstructured":"Livingston G, Huntley J, Sommerlad A, Ames D, Ballard C, Banerjee S, et al. Dementia prevention, intervention, and care: 2020 report of the lancet commission. Lancet. 2020;396(10248):413\u201346.","journal-title":"Lancet"},{"issue":"10","key":"478_CR11","doi-asserted-by":"publisher","first-page":"3105","DOI":"10.1007\/s00415-020-09926-w","volume":"267","author":"S Fordington","year":"2020","unstructured":"Fordington S, Manford M. A review of seizures and epilepsy following traumatic brain injury. J Neurol. 2020;267(10):3105\u201311.","journal-title":"J Neurol"},{"issue":"24","key":"478_CR12","doi-asserted-by":"publisher","first-page":"e3248","DOI":"10.1212\/WNL.0000000000011080","volume":"95","author":"EL Johnson","year":"2020","unstructured":"Johnson EL, Krauss GL, Kucharska-Newton A, Albert MS, Brandt J, Walker KA, et al. Dementia in late-onset epilepsy: the Atherosclerosis risk in communities study. Neurology. 2020;95(24):e3248\u201356.","journal-title":"Neurology"},{"issue":"4","key":"478_CR13","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1001\/jamaneurol.2024.0010","volume":"81","author":"ALC Schneider","year":"2024","unstructured":"Schneider ALC, Law CA, Gottesman RF, Krauss G, Huang J, Kucharska-Newton A, et al. Posttraumatic epilepsy and dementia risk. JAMA Neurol. 2024;81(4):346\u201353.","journal-title":"JAMA Neurol"},{"issue":"3","key":"478_CR14","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.neuron.2019.06.002","volume":"103","author":"DK Sandsmark","year":"2019","unstructured":"Sandsmark DK, Bashir A, Wellington CL, Diaz-Arrastia R. Cerebral microvascular injury: a potentially treatable endophenotype of traumatic brain injury-induced neurodegeneration. Neuron. 2019;103(3):367\u201379.","journal-title":"Neuron"},{"key":"478_CR15","doi-asserted-by":"publisher","first-page":"16084","DOI":"10.1038\/nrdp.2016.84","volume":"2","author":"K Blennow","year":"2016","unstructured":"Blennow K, Brody DL, Kochanek PM, Levin H, McKee A, Ribbers GM, et al. Traumatic brain injuries. Nat Rev Dis Primers. 2016;2:16084.","journal-title":"Nat Rev Dis Primers"},{"issue":"9","key":"478_CR16","first-page":"2685","volume":"141","author":"ER Zanier","year":"2018","unstructured":"Zanier ER, Bertani I, Sammali E, Pischiutta F, Chiaravalloti MA, Vegliante G, et al. Induction of a transmissible tau pathology by traumatic brain injury. Brain. 2018;141(9):2685\u201399.","journal-title":"Brain"},{"issue":"10","key":"478_CR17","doi-asserted-by":"publisher","first-page":"3265","DOI":"10.1093\/brain\/awz238","volume":"142","author":"K Takahata","year":"2019","unstructured":"Takahata K, Kimura Y, Sahara N, Koga S, Shimada H, Ichise M, et al. PET-detectable tau pathology correlates with long-term neuropsychiatric outcomes in patients with traumatic brain injury. Brain. 2019;142(10):3265\u201379.","journal-title":"Brain"},{"issue":"2","key":"478_CR18","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1093\/brain\/awx350","volume":"141","author":"CA Tagge","year":"2018","unstructured":"Tagge CA, Fisher AM, Minaeva OV, Gaudreau-Balderrama A, Moncaster JA, Zhang XL, et al. Concussion, microvascular injury, and early tauopathy in young athletes after impact head injury and an impact concussion mouse model. Brain. 2018;141(2):422\u201358.","journal-title":"Brain"},{"issue":"1","key":"478_CR19","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s40478-021-01220-8","volume":"9","author":"A Kahriman","year":"2021","unstructured":"Kahriman A, Bouley J, Smith TW, Bosco DA, Woerman AL, Henninger N. Mouse closed head traumatic brain injury replicates the histological tau pathology pattern of human disease: characterization of a novel model and systematic review of the literature. Acta Neuropathol Commun. 2021;9(1):118.","journal-title":"Acta Neuropathol Commun"},{"key":"478_CR20","volume":"328","author":"N Panayi","year":"2024","unstructured":"Panayi N, Schulz P, He P, Hanna B, Lifshitz J, Rowe RK, et al. Traumatic brain injury in mice generates early-stage Alzheimer\u2019s disease related protein pathology that correlates with neurobehavioral deficits. Mol Neurobiol. 2024;328: 113257.","journal-title":"Mol Neurobiol"},{"key":"478_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.pneurobio.2019.101730","volume":"185","author":"Z Wu","year":"2020","unstructured":"Wu Z, Wang ZH, Liu X, Zhang Z, Gu X, Yu SP, et al. Traumatic brain injury triggers APP and Tau cleavage by delta-secretase, mediating Alzheimer\u2019s disease pathology. Prog Neurobiol. 2020;185: 101730.","journal-title":"Prog Neurobiol"},{"issue":"10","key":"478_CR22","doi-asserted-by":"publisher","first-page":"2715","DOI":"10.1016\/j.cell.2021.03.032","volume":"184","author":"MK Shin","year":"2021","unstructured":"Shin MK, Vazquez-Rosa E, Koh Y, Dhar M, Chaubey K, Cintron-Perez CJ, et al. Reducing acetylated tau is neuroprotective in brain injury. Cell. 2021;184(10):2715-32e23.","journal-title":"Cell"},{"issue":"1","key":"478_CR23","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s13024-024-00733-9","volume":"19","author":"C Parra Bravo","year":"2024","unstructured":"Parra Bravo C, Krukowski K, Barker S, Wang C, Li Y, Fan L, et al. Anti-acetylated-tau immunotherapy is neuroprotective in tauopathy and brain injury. Mol Neurodegener. 2024;19(1):51.","journal-title":"Mol Neurodegener"},{"issue":"1","key":"478_CR24","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1152\/physrev.00050.2017","volume":"99","author":"MD Sweeney","year":"2019","unstructured":"Sweeney MD, Zhao Z, Montagne A, Nelson AR, Zlokovic BV. Blood-brain barrier: from physiology to disease and back. Physiol Rev. 2019;99(1):21\u201378.","journal-title":"Physiol Rev"},{"issue":"6","key":"478_CR25","doi-asserted-by":"publisher","first-page":"2659","DOI":"10.1038\/s41380-022-01511-z","volume":"27","author":"EG Knox","year":"2022","unstructured":"Knox EG, Aburto MR, Clarke G, Cryan JF, O\u2019Driscoll CM. The blood-brain barrier in aging and neurodegeneration. Mol Psychiatry. 2022;27(6):2659\u201373.","journal-title":"Mol Psychiatry"},{"key":"478_CR26","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1146\/annurev-neuro-091922-031205","volume":"46","author":"B Diaz-Castro","year":"2023","unstructured":"Diaz-Castro B, Robel S, Mishra A. Astrocyte endfeet in brain function and pathology: open questions. Annu Rev Neurosci. 2023;46:101\u201321.","journal-title":"Annu Rev Neurosci"},{"key":"478_CR27","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1038\/s41582-024-00973-9","volume":"20","author":"G van Hameren","year":"2024","unstructured":"van Hameren G, Aboghazleh R, Parker E, Dreier JP, Kaufer D, Friedman A. From spreading depolarization to blood-brain barrier dysfunction: navigating traumatic brain injury for novel diagnosis and therapy. Nat Rev Neurol. 2024;20:408.","journal-title":"Nat Rev Neurol"},{"issue":"5","key":"478_CR28","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1007\/s00401-018-1824-0","volume":"135","author":"VE Johnson","year":"2018","unstructured":"Johnson VE, Weber MT, Xiao R, Cullen DK, Meaney DF, Stewart W, et al. Mechanical disruption of the blood-brain barrier following experimental concussion. Acta Neuropathol. 2018;135(5):711\u201326.","journal-title":"Acta Neuropathol"},{"issue":"12","key":"478_CR29","first-page":"1147","volume":"74","author":"JR Hay","year":"2015","unstructured":"Hay JR, Johnson VE, Young AMH, Smith DH, Stewart W. Blood-brain barrier disruption is an early event that may persist for many years after traumatic brain injury in humans. J Neuropathol Exp Neurol. 2015;74(12):1147\u201357.","journal-title":"J Neuropathol Exp Neurol"},{"key":"478_CR30","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.3389\/fphys.2020.01030","volume":"11","author":"Y Wu","year":"2020","unstructured":"Wu Y, Wu H, Guo X, Pluimer B, Zhao Z. Blood-brain barrier dysfunction in mild traumatic brain injury: evidence from preclinical murine models. Front Physiol. 2020;11:1030.","journal-title":"Front Physiol"},{"key":"478_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2020.113257","volume":"328","author":"EE Abrahamson","year":"2020","unstructured":"Abrahamson EE, Ikonomovic MD. Brain injury-induced dysfunction of the blood brain barrier as a risk for dementia. Exp Neurol. 2020;328: 113257.","journal-title":"Exp Neurol"},{"key":"478_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2022.108119","volume":"234","author":"G Nehra","year":"2022","unstructured":"Nehra G, Bauer B, Hartz AMS. Blood-brain barrier leakage in Alzheimer\u2019s disease: from discovery to clinical relevance. Pharmacol Ther. 2022;234: 108119.","journal-title":"Pharmacol Ther"},{"issue":"3","key":"478_CR33","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/nrneurol.2017.188","volume":"14","author":"MD Sweeney","year":"2018","unstructured":"Sweeney MD, Sagare AP, Zlokovic BV. Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders. Nat Rev Neurol. 2018;14(3):133\u201350.","journal-title":"Nat Rev Neurol"},{"issue":"6","key":"478_CR34","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1093\/brain\/awab450","volume":"145","author":"E Parker","year":"2022","unstructured":"Parker E, Aboghazleh R, Mumby G, Veksler R, Ofer J, Newton J, et al. Concussion susceptibility is mediated by spreading depolarization-induced neurovascular dysfunction. Brain. 2022;145(6):2049\u201363.","journal-title":"Brain"},{"issue":"1","key":"478_CR35","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s40478-021-01178-7","volume":"9","author":"Y Wu","year":"2021","unstructured":"Wu Y, Wu H, Zeng J, Pluimer B, Dong S, Xie X, et al. Mild traumatic brain injury induces microvascular injury and accelerates Alzheimer-like pathogenesis in mice. Acta Neuropathol Commun. 2021;9(1):74.","journal-title":"Acta Neuropathol Commun"},{"issue":"1\u20132","key":"478_CR36","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1089\/neu.2021.0204","volume":"39","author":"KK George","year":"2022","unstructured":"George KK, Heithoff BP, Shandra O, Robel S. Mild traumatic brain injury\/concussion initiates an atypical astrocyte response caused by blood-brain barrier dysfunction. J Neurotrauma. 2022;39(1\u20132):211\u201326.","journal-title":"J Neurotrauma"},{"issue":"44","key":"478_CR37","doi-asserted-by":"publisher","first-page":"27667","DOI":"10.1073\/pnas.2010430117","volume":"117","author":"E Vazquez-Rosa","year":"2020","unstructured":"Vazquez-Rosa E, Shin MK, Dhar M, Chaubey K, Cintron-Perez CJ, Tang X, et al. P7C3-A20 treatment one year after TBI in mice repairs the blood-brain barrier, arrests chronic neurodegeneration, and restores cognition. Proc Natl Acad Sci U S A. 2020;117(44):27667\u201375.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"478_CR38","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12987-021-00283-y","volume":"18","author":"M Eisenbaum","year":"2021","unstructured":"Eisenbaum M, Pearson A, Gratkowski A, Mouzon B, Mullan M, Crawford F, et al. Influence of traumatic brain injury on extracellular tau elimination at the blood-brain barrier. Fluids Barriers CNS. 2021;18(1):48.","journal-title":"Fluids Barriers CNS"},{"key":"478_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2020.105237","volume":"150","author":"J Ojo","year":"2021","unstructured":"Ojo J, Eisenbaum M, Shackleton B, Lynch C, Joshi U, Saltiel N, et al. Mural cell dysfunction leads to altered cerebrovascular tau uptake following repetitive head trauma. Neurobiol Dis. 2021;150: 105237.","journal-title":"Neurobiol Dis"},{"key":"478_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2024.114702","volume":"374","author":"M Eisenbaum","year":"2024","unstructured":"Eisenbaum M, Pearson A, Ortiz C, Koprivica M, Cembran A, Mullan M, et al. Repetitive head trauma and apoE4 induce chronic cerebrovascular alterations that impair tau elimination from the brain. Exp Neurol. 2024;374: 114702.","journal-title":"Exp Neurol"},{"key":"478_CR41","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.nbd.2018.06.022","volume":"123","author":"A Dadas","year":"2019","unstructured":"Dadas A, Janigro D. Breakdown of blood brain barrier as a mechanism of post-traumatic epilepsy. Neurobiol Dis. 2019;123:20\u20136.","journal-title":"Neurobiol Dis"},{"issue":"3","key":"478_CR42","doi-asserted-by":"publisher","DOI":"10.1111\/nan.12782","volume":"48","author":"C Kurz","year":"2022","unstructured":"Kurz C, Walker L, Rauchmann BS, Perneczky R. Dysfunction of the blood-brain barrier in Alzheimer\u2019s disease: evidence from human studies. Neuropathol Appl Neurobiol. 2022;48(3): e12782.","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"1","key":"478_CR43","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1002\/alz.13433","volume":"20","author":"A Puig-Pijoan","year":"2024","unstructured":"Puig-Pijoan A, Jimenez-Balado J, Fernandez-Lebrero A, Garcia-Escobar G, Navalpotro-Gomez I, Contador J, et al. Risk of cognitive decline progression is associated to increased blood-brain-barrier permeability: a longitudinal study in a memory unit clinical cohort. Alzheimers Dement. 2024;20(1):538\u201348.","journal-title":"Alzheimers Dement"},{"issue":"24","key":"478_CR44","doi-asserted-by":"publisher","first-page":"4541","DOI":"10.1523\/JNEUROSCI.0237-23.2023","volume":"43","author":"A Bryant","year":"2023","unstructured":"Bryant A, Li Z, Jayakumar R, Serrano-Pozo A, Woost B, Hu M, et al. Endothelial cells are heterogeneous in different brain regions and are dramatically altered in Alzheimer\u2019s disease. J Neurosci. 2023;43(24):4541\u201357.","journal-title":"J Neurosci"},{"issue":"6","key":"478_CR45","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1038\/s41593-023-01334-3","volume":"26","author":"N Sun","year":"2023","unstructured":"Sun N, Akay LA, Murdock MH, Park Y, Galiana-Melendez F, Bubnys A, et al. Single-nucleus multiregion transcriptomic analysis of brain vasculature in Alzheimer\u2019s disease. Nat Neurosci. 2023;26(6):970\u201382.","journal-title":"Nat Neurosci"},{"issue":"1","key":"478_CR46","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1038\/s41467-024-46630-z","volume":"15","author":"S Tsartsalis","year":"2024","unstructured":"Tsartsalis S, Sleven H, Fancy N, Wessely F, Smith AM, Willumsen N, et al. A single nuclear transcriptomic characterisation of mechanisms responsible for impaired angiogenesis and blood-brain barrier function in Alzheimer\u2019s disease. Nat Commun. 2024;15(1):2243.","journal-title":"Nat Commun"},{"issue":"7903","key":"478_CR47","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1038\/s41586-021-04369-3","volume":"603","author":"AC Yang","year":"2022","unstructured":"Yang AC, Vest RT, Kern F, Lee DP, Agam M, Maat CA, et al. A human brain vascular atlas reveals diverse mediators of Alzheimer\u2019s risk. Nature. 2022;603(7903):885\u201392.","journal-title":"Nature"},{"issue":"21","key":"478_CR48","doi-asserted-by":"publisher","first-page":"eadn7655","DOI":"10.1126\/sciadv.adn7655","volume":"10","author":"CX Yap","year":"2024","unstructured":"Yap CX, Vo DD, Heffel MG, Bhattacharya A, Wen C, Yang Y, et al. Brain cell-type shifts in Alzheimer\u2019s disease, autism, and schizophrenia interrogated using methylomics and genetics. Sci Adv. 2024;10(21):eadn7655.","journal-title":"Sci Adv"},{"issue":"5","key":"478_CR49","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1093\/brain\/awab050","volume":"144","author":"M Ries","year":"2021","unstructured":"Ries M, Watts H, Mota BC, Lopez MY, Donat CK, Baxan N, et al. Annexin A1 restores cerebrovascular integrity concomitant with reduced amyloid-\u03b2 and tau pathology. Brain. 2021;144(5):1526\u201341.","journal-title":"Brain"},{"issue":"2","key":"478_CR50","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.neuron.2015.09.036","volume":"88","author":"N Bien-Ly","year":"2015","unstructured":"Bien-Ly N, Boswell CA, Jeet S, Beach TG, Hoyte K, Luk W, et al. Lack of widespread BBB disruption in Alzheimer\u2019s disease models: focus on therapeutic antibodies. Neuron. 2015;88(2):289\u201397.","journal-title":"Neuron"},{"issue":"3","key":"478_CR51","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.3390\/ijms22031231","volume":"22","author":"IM Abdallah","year":"2021","unstructured":"Abdallah IM, Al-Shami KM, Yang E, Kaddoumi A. Blood-brain barrier disruption increases amyloid-related pathology in TgSwDI mice. Int J Mol Sci. 2021;22(3):1231.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"478_CR52","doi-asserted-by":"publisher","first-page":"8463","DOI":"10.1038\/s41467-023-44319-3","volume":"14","author":"J Lee","year":"2023","unstructured":"Lee J, Lee H, Lee H, Shin M, Shin MG, Seo J, et al. ANKS1A regulates LDL receptor-related protein 1 (LRP1)-mediated cerebrovascular clearance in brain endothelial cells. Nat Commun. 2023;14(1):8463.","journal-title":"Nat Commun"},{"key":"478_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2021.147569","volume":"1767","author":"Z Bian","year":"2021","unstructured":"Bian Z, Yamashita T, Shi X, Feng T, Yu H, Hu X, et al. Accelerated accumulation of fibrinogen peptide chains with Abeta deposition in Alzheimer\u2019s disease (AD) mice and human AD brains. Brain Res. 2021;1767: 147569.","journal-title":"Brain Res"},{"issue":"5","key":"478_CR54","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/nrn.2018.13","volume":"19","author":"MA Petersen","year":"2018","unstructured":"Petersen MA, Ryu JK, Akassoglou K. Fibrinogen in neurological diseases: mechanisms, imaging and therapeutics. Nat Rev Neurosci. 2018;19(5):283\u2013301.","journal-title":"Nat Rev Neurosci"},{"issue":"11","key":"478_CR55","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1038\/s41590-018-0232-x","volume":"19","author":"JK Ryu","year":"2018","unstructured":"Ryu JK, Rafalski VA, Meyer-Franke A, Adams RA, Poda SB, Rios Coronado PE, et al. Fibrin-targeting immunotherapy protects against neuroinflammation and neurodegeneration. Nat Immunol. 2018;19(11):1212\u201323.","journal-title":"Nat Immunol"},{"issue":"1","key":"478_CR56","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s00401-024-02696-z","volume":"147","author":"YC Wu","year":"2024","unstructured":"Wu YC, Bogale TA, Koistinaho J, Pizzi M, Rolova T, Bellucci A. The contribution of \u03b2-amyloid, Tau and \u03b1-synuclein to blood-brain barrier damage in neurodegenerative disorders. Acta Neuropathol. 2024;147(1):39.","journal-title":"Acta Neuropathol"},{"key":"478_CR57","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2021.695479","volume":"15","author":"D Wang","year":"2021","unstructured":"Wang D, Chen F, Han Z, Yin Z, Ge X, Lei P. Relationship between amyloid-beta deposition and blood-brain barrier dysfunction in Alzheimer\u2019s disease. Front Cell Neurosci. 2021;15: 695479.","journal-title":"Front Cell Neurosci"},{"issue":"11","key":"478_CR58","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13258","volume":"19","author":"R Parodi-Rullan","year":"2020","unstructured":"Parodi-Rullan R, Ghiso J, Cabrera E, Rostagno A, Fossati S. Alzheimer\u2019s amyloid beta heterogeneous species differentially affect brain endothelial cell viability, blood-brain barrier integrity, and angiogenesis. Aging Cell. 2020;19(11): e13258.","journal-title":"Aging Cell"},{"key":"478_CR59","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s40478-015-0186-2","volume":"3","author":"LJ Blair","year":"2015","unstructured":"Blair LJ, Frauen HD, Zhang B, Nordhues BA, Bijan S, Lin YC, et al. Tau depletion prevents progressive blood-brain barrier damage in a mouse model of tauopathy. Acta Neuropathol Commun. 2015;3:8.","journal-title":"Acta Neuropathol Commun"},{"key":"478_CR60","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2020.570045","volume":"13","author":"A Michalicova","year":"2020","unstructured":"Michalicova A, Majerova P, Kovac A. Tau protein and its role in blood-brain barrier dysfunction. Front Mol Neurosci. 2020;13: 570045.","journal-title":"Front Mol Neurosci"},{"issue":"1","key":"478_CR61","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.1038\/s41467-023-37840-y","volume":"14","author":"SA Hussong","year":"2023","unstructured":"Hussong SA, Banh AQ, Van Skike CE, Dorigatti AO, Hernandez SF, Hart MJ, et al. Soluble pathogenic tau enters brain vascular endothelial cells and drives cellular senescence and brain microvascular dysfunction in a mouse model of tauopathy. Nat Commun. 2023;14(1):2367.","journal-title":"Nat Commun"},{"issue":"2","key":"478_CR62","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/s41583-023-00776-9","volume":"25","author":"J Blumenfeld","year":"2024","unstructured":"Blumenfeld J, Yip O, Kim MJ, Huang Y. Cell type-specific roles of APOE4 in Alzheimer disease. Nat Rev Neurosci. 2024;25(2):91\u2013110.","journal-title":"Nat Rev Neurosci"},{"key":"478_CR63","doi-asserted-by":"publisher","first-page":"105790","DOI":"10.1016\/j.bandc.2021.105790","volume":"154","author":"VC Merritt","year":"2021","unstructured":"Merritt VC, Lange RT, Lippa SM, Brickell TA, Soltis AR, Dalgard CL, et al. Apolipoprotein e (APOE) \u03b54 genotype influences memory performance following remote traumatic brain injury in U.S. military service members and veterans. Brain Cogn. 2021;154:105790.","journal-title":"Brain Cogn"},{"key":"478_CR64","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.neurobiolaging.2022.03.011","volume":"115","author":"Y Li","year":"2022","unstructured":"Li Y, Macyczko JR, Liu CC, Bu G. ApoE4 reduction: an emerging and promising therapeutic strategy for Alzheimer\u2019s disease. Neurobiol Aging. 2022;115:20\u20138.","journal-title":"Neurobiol Aging"},{"issue":"7399","key":"478_CR65","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/nature11087","volume":"485","author":"RD Bell","year":"2012","unstructured":"Bell RD, Winkler EA, Singh I, Sagare AP, Deane R, Wu Z, et al. Apolipoprotein E controls cerebrovascular integrity via cyclophilin A. Nature. 2012;485(7399):512\u20136.","journal-title":"Nature"},{"issue":"10","key":"478_CR66","doi-asserted-by":"publisher","first-page":"3582","DOI":"10.1093\/brain\/awab478","volume":"145","author":"RJ Jackson","year":"2022","unstructured":"Jackson RJ, Meltzer JC, Nguyen H, Commins C, Bennett RE, Hudry E, et al. APOE4 derived from astrocytes leads to blood-brain barrier impairment. Brain. 2022;145(10):3582\u201393.","journal-title":"Brain"},{"issue":"11","key":"478_CR67","doi-asserted-by":"publisher","first-page":"e20221137","DOI":"10.1084\/jem.20221137","volume":"219","author":"G Barisano","year":"2022","unstructured":"Barisano G, Kisler K, Wilkinson B, Nikolakopoulou AM, Sagare AP, Wang Y, et al. A \u201cmulti-omics\u201d analysis of blood-brain barrier and synaptic dysfunction in APOE4 mice. J Exp Med. 2022;219(11):e20221137.","journal-title":"J Exp Med"},{"key":"478_CR68","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.neurobiolaging.2024.04.003","volume":"140","author":"I Libri","year":"2024","unstructured":"Libri I, Silvestri C, Caratozzolo S, Alberici A, Pilotto A, Archetti S, et al. Association of APOE genotype with blood-brain barrier permeability in neurodegenerative disorders. Neurobiol Aging. 2024;140:33\u201340.","journal-title":"Neurobiol Aging"},{"issue":"7806","key":"478_CR69","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s41586-020-2247-3","volume":"581","author":"A Montagne","year":"2020","unstructured":"Montagne A, Nation DA, Sagare AP, Barisano G, Sweeney MD, Chakhoyan A, et al. APOE4 leads to blood-brain barrier dysfunction predicting cognitive decline. Nature. 2020;581(7806):71\u20136.","journal-title":"Nature"},{"issue":"6","key":"478_CR70","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1038\/s43587-021-00073-z","volume":"1","author":"A Montagne","year":"2021","unstructured":"Montagne A, Nikolakopoulou AM, Huuskonen MT, Sagare AP, Lawson EJ, Lazic D, et al. APOE4 accelerates advanced-stage vascular and neurodegenerative disorder in old Alzheimer\u2019s mice via cyclophilin A independently of amyloid-beta. Nat Aging. 2021;1(6):506\u201320.","journal-title":"Nat Aging"},{"issue":"1","key":"478_CR71","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s13024-018-0249-5","volume":"13","author":"BS Main","year":"2018","unstructured":"Main BS, Villapol S, Sloley SS, Barton DJ, Parsadanian M, Agbaegbu C, et al. Apolipoprotein E4 impairs spontaneous blood brain barrier repair following traumatic brain injury. Mol Neurodegener. 2018;13(1):17.","journal-title":"Mol Neurodegener"},{"key":"478_CR72","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.neurobiolaging.2020.06.018","volume":"95","author":"C Ringland","year":"2020","unstructured":"Ringland C, Schweig JE, Paris D, Shackleton B, Lynch CE, Eisenbaum M, et al. Apolipoprotein E isoforms differentially regulate matrix metallopeptidase 9 function in Alzheimer\u2019s disease. Neurobiol Aging. 2020;95:56\u201368.","journal-title":"Neurobiol Aging"},{"issue":"1","key":"478_CR73","doi-asserted-by":"publisher","first-page":"19919","DOI":"10.1038\/s41598-020-76849-x","volume":"10","author":"AO Giarratana","year":"2020","unstructured":"Giarratana AO, Zheng C, Reddi S, Teng SL, Berger D, Adler D, et al. APOE4 genetic polymorphism results in impaired recovery in a repeated mild traumatic brain injury model and treatment with Bryostatin-1 improves outcomes. Sci Rep. 2020;10(1):19919.","journal-title":"Sci Rep"},{"issue":"8","key":"478_CR74","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1001\/jamaneurol.2022.1634","volume":"79","author":"K Atherton","year":"2022","unstructured":"Atherton K, Han X, Chung J, Cherry JD, Baucom Z, Saltiel N, et al. Association of APOE genotypes and chronic traumatic encephalopathy. JAMA Neurol. 2022;79(8):787\u201396.","journal-title":"JAMA Neurol"},{"key":"478_CR75","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2021.100715","volume":"296","author":"JM Cooper","year":"2021","unstructured":"Cooper JM, Lathuiliere A, Migliorini M, Arai AL, Wani MM, Dujardin S, et al. Regulation of tau internalization, degradation, and seeding by LRP1 reveals multiple pathways for tau catabolism. J Biol Chem. 2021;296: 100715.","journal-title":"J Biol Chem"},{"issue":"3","key":"478_CR76","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.neuron.2020.11.019","volume":"109","author":"Y Yamazaki","year":"2021","unstructured":"Yamazaki Y, Liu CC, Yamazaki A, Shue F, Martens YA, Chen Y, et al. Vascular ApoE4 impairs behavior by modulating gliovascular function. Neuron. 2021;109(3):438-47.e6.","journal-title":"Neuron"},{"issue":"11","key":"478_CR77","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1038\/s41593-024-01757-6","volume":"27","author":"A Anfray","year":"2024","unstructured":"Anfray A, Schaeffer S, Hattori Y, Santisteban MM, Casey N, Wang G, et al. A cell-autonomous role for border-associated macrophages in ApoE4 neurovascular dysfunction and susceptibility to white matter injury. Nat Neurosci. 2024;27(11):2138\u201351.","journal-title":"Nat Neurosci"},{"issue":"8","key":"478_CR78","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1038\/s41593-022-01127-0","volume":"25","author":"CC Liu","year":"2022","unstructured":"Liu CC, Zhao J, Fu Y, Inoue Y, Ren Y, Chen Y, et al. Peripheral apoE4 enhances Alzheimer\u2019s pathology and impairs cognition by compromising cerebrovascular function. Nat Neurosci. 2022;25(8):1020\u201333.","journal-title":"Nat Neurosci"},{"issue":"4","key":"478_CR79","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1002\/ana.26864","volume":"95","author":"JM Vance","year":"2024","unstructured":"Vance JM, Farrer LA, Huang Y, Cruchaga C, Hyman BT, Pericak-Vance MA, et al. Report of the APOE4 National Institute on Aging\/Alzheimer Disease Sequencing Project Consortium Working Group: Reducing APOE4 in carriers is a therapeutic goal for Alzheimer\u2019s disease. Ann Neurol. 2024;95(4):625\u201334.","journal-title":"Ann Neurol"},{"issue":"8","key":"478_CR80","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/s41582-024-00988-2","volume":"20","author":"RJ Jackson","year":"2024","unstructured":"Jackson RJ, Hyman BT, Serrano-Pozo A. Multifaceted roles of APOE in Alzheimer disease. Nat Rev Neurol. 2024;20(8):457\u201374.","journal-title":"Nat Rev Neurol"},{"issue":"5","key":"478_CR81","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1002\/ana.26043","volume":"89","author":"A Litvinchuk","year":"2021","unstructured":"Litvinchuk A, Huynh TV, Shi Y, Jackson RJ, Finn MB, Manis M, et al. Apolipoprotein E4 reduction with antisense oligonucleotides decreases neurodegeneration in a tauopathy model. Ann Neurol. 2021;89(5):952\u201366.","journal-title":"Ann Neurol"},{"issue":"4","key":"478_CR82","doi-asserted-by":"publisher","first-page":"2632","DOI":"10.1002\/alz.13703","volume":"20","author":"CM Ferguson","year":"2024","unstructured":"Ferguson CM, Hildebrand S, Godinho B, Buchwald J, Echeverria D, Coles A, et al. Silencing Apoe with divalent-siRNAs improves amyloid burden and activates immune response pathways in Alzheimer\u2019s disease. Alzheimers Dement. 2024;20(4):2632\u201352.","journal-title":"Alzheimers Dement"},{"issue":"581","key":"478_CR83","doi-asserted-by":"publisher","first-page":"eabd7522","DOI":"10.1126\/scitranslmed.abd7522","volume":"13","author":"M Xiong","year":"2021","unstructured":"Xiong M, Jiang H, Serrano JR, Gonzales ER, Wang C, Gratuze M, et al. APOE immunotherapy reduces cerebral amyloid angiopathy and amyloid plaques while improving cerebrovascular function. Sci Transl Med.\u00a02021;13(581):eabd7522.","journal-title":"Sci Transl Med"},{"issue":"4","key":"478_CR84","doi-asserted-by":"publisher","first-page":"828","DOI":"10.14336\/AD.2020.0222","volume":"11","author":"M Kandasamy","year":"2020","unstructured":"Kandasamy M, Anusuyadevi M, Aigner KM, Unger MS, Kniewallner KM, de Sousa DMB, et al. TGF-beta signaling: a therapeutic target to reinstate regenerative plasticity in vascular dementia? Aging Dis. 2020;11(4):828\u201350.","journal-title":"Aging Dis"},{"issue":"11","key":"478_CR85","doi-asserted-by":"publisher","first-page":"2468","DOI":"10.3390\/biomedicines12112468","volume":"12","author":"L Li","year":"2024","unstructured":"Li L, Sun B, Harris OA, Luo J. TGF-\u03b2 signaling in microglia: a key regulator of development, homeostasis and reactivity. Biomedicines. 2024;12(11):2468.","journal-title":"Biomedicines"},{"issue":"5","key":"478_CR86","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3390\/biomedicines10051206","volume":"10","author":"J Luo","year":"2022","unstructured":"Luo J. TGF-beta as a key modulator of astrocyte reactivity: disease relevance and therapeutic implications. Biomedicines. 2022;10(5):5.","journal-title":"Biomedicines"},{"issue":"9","key":"478_CR87","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.tcb.2010.06.006","volume":"20","author":"E Pardali","year":"2010","unstructured":"Pardali E, Goumans MJ, ten Dijke P. Signaling by members of the TGF-beta family in vascular morphogenesis and disease. Trends Cell Biol. 2010;20(9):556\u201367.","journal-title":"Trends Cell Biol"},{"issue":"7","key":"478_CR88","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0103174","volume":"9","author":"JH Seo","year":"2014","unstructured":"Seo JH, Maki T, Maeda M, Miyamoto N, Liang AC, Hayakawa K, et al. Oligodendrocyte precursor cells support blood-brain barrier integrity via TGF-beta signaling. PLoS ONE. 2014;9(7): e103174.","journal-title":"PLoS ONE"},{"issue":"3","key":"478_CR89","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.devcel.2011.01.011","volume":"20","author":"F Li","year":"2011","unstructured":"Li F, Lan Y, Wang Y, Wang J, Yang G, Meng F, et al. Endothelial Smad4 maintains cerebrovascular integrity by activating N-cadherin through cooperation with Notch. Dev Cell. 2011;20(3):291\u2013302.","journal-title":"Dev Cell"},{"issue":"6","key":"478_CR90","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1038\/jcbfm.2009.32","volume":"29","author":"PT Ronaldson","year":"2009","unstructured":"Ronaldson PT, Demarco KM, Sanchez-Covarrubias L, Solinsky CM, Davis TP. Transforming growth factor-beta signaling alters substrate permeability and tight junction protein expression at the blood-brain barrier during inflammatory pain. J Cereb Blood Flow Metab. 2009;29(6):1084\u201398.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"2","key":"478_CR91","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41419-018-1294-2","volume":"10","author":"C Derada Troletti","year":"2019","unstructured":"Derada Troletti C, Fontijn RD, Gowing E, Charabati M, van Het Hof B, Didouh I, et al. Inflammation-induced endothelial to mesenchymal transition promotes brain endothelial cell dysfunction and occurs during multiple sclerosis pathophysiology. Cell Death Dis. 2019;10(2):45.","journal-title":"Cell Death Dis"},{"issue":"1","key":"478_CR92","doi-asserted-by":"publisher","first-page":"4758","DOI":"10.1038\/s41467-024-48926-6","volume":"15","author":"\u00d6 \u0130\u015f","year":"2024","unstructured":"\u0130\u015f \u00d6, Wang X, Reddy JS, Min Y, Yilmaz E, Bhattarai P, et al. Gliovascular transcriptional perturbations in Alzheimer\u2019s disease reveal molecular mechanisms of blood brain barrier dysfunction. Nat Commun. 2024;15(1):4758.","journal-title":"Nat Commun"},{"issue":"7501","key":"478_CR93","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/nature13324","volume":"509","author":"A Ben-Zvi","year":"2014","unstructured":"Ben-Zvi A, Lacoste B, Kur E, Andreone BJ, Mayshar Y, Yan H, et al. Mfsd2a is critical for the formation and function of the blood-brain barrier. Nature. 2014;509(7501):507\u201311.","journal-title":"Nature"},{"key":"478_CR94","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.conb.2018.12.014","volume":"57","author":"S Ayloo","year":"2019","unstructured":"Ayloo S, Gu C. Transcytosis at the blood\u2013brain barrier. Curr Opin Neurobiol. 2019;57:32\u20138.","journal-title":"Curr Opin Neurobiol"},{"issue":"3","key":"478_CR95","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.neuron.2017.03.043","volume":"94","author":"BJ Andreone","year":"2017","unstructured":"Andreone BJ, Chow BW, Tata A, Lacoste B, Ben-Zvi A, Bullock K, et al. Blood-brain barrier permeability is regulated by lipid transport-dependent suppression of caveolae-mediated transcytosis. Neuron. 2017;94(3):581-94e5.","journal-title":"Neuron"},{"key":"478_CR96","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2020.113203","volume":"326","author":"P Eser Ocak","year":"2020","unstructured":"Eser Ocak P, Ocak U, Sherchan P, Gamdzyk M, Tang J, Zhang JH. Overexpression of Mfsd2a attenuates blood brain barrier dysfunction via Cav-1\/Keap-1\/Nrf-2\/HO-1 pathway in a rat model of surgical brain injury. Exp Neurol. 2020;326: 113203.","journal-title":"Exp Neurol"},{"issue":"1","key":"478_CR97","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s12987-022-00356-6","volume":"19","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Wang L, Pan Q, Yang X, Cao Y, Yan J, et al. Selective sphingosine-1-phosphate receptor 1 modulator attenuates blood-brain barrier disruption following traumatic brain injury by inhibiting vesicular transcytosis. Fluids Barriers CNS. 2022;19(1):57.","journal-title":"Fluids Barriers CNS"},{"key":"478_CR98","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2024.114782","volume":"377","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Xu J, Li P, Luo B, Tang H. Activation of Wnt signaling mitigates blood-brain barrier disruption by inhibiting vesicular transcytosis after traumatic brain injury in mice. Exp Neurol. 2024;377: 114782.","journal-title":"Exp Neurol"},{"issue":"1","key":"478_CR99","doi-asserted-by":"publisher","first-page":"70","DOI":"10.3390\/ijms21010070","volume":"21","author":"M Sanchez-Campillo","year":"2019","unstructured":"Sanchez-Campillo M, Ruiz-Pastor MJ, Gazquez A, Marin-Munoz J, Noguera-Perea F, Ruiz-Alcaraz AJ, et al. Decreased blood level of MFSD2a as a potential biomarker of Alzheimer\u2019s disease. Int J Mol Sci. 2019;21(1):70.","journal-title":"Int J Mol Sci"},{"issue":"18","key":"478_CR100","doi-asserted-by":"publisher","first-page":"14092","DOI":"10.3390\/ijms241814092","volume":"24","author":"I Jovanovic Macura","year":"2023","unstructured":"Jovanovic Macura I, Zivanovic A, Perovic M, Ciric J, Major T, Kanazir S, et al. The expression of major facilitator superfamily domain-containing protein2a (Mfsd2a) and aquaporin 4 is altered in the retinas of a 5xFAD mouse model of Alzheimer\u2019s disease. Int J Mol Sci. 2023;24(18):14092.","journal-title":"Int J Mol Sci"},{"issue":"S3","key":"478_CR101","doi-asserted-by":"publisher","DOI":"10.1002\/alz.067434","volume":"18","author":"A Nkiliza","year":"2022","unstructured":"Nkiliza A, Evans J, Ringland C, Daniel N, Huguenard C, David R, et al. APOE e4 dependent deficits in brain DHA phospholipids and mfsd2a in Alzheimer\u2019s disease patients with severe cerebral amyloid angiopathy. Alzheimers Dement. 2022;18(S3): e067434.","journal-title":"Alzheimers Dement"},{"key":"478_CR102","doi-asserted-by":"publisher","first-page":"461","DOI":"10.3389\/fnins.2020.00461","volume":"14","author":"C Qu","year":"2020","unstructured":"Qu C, Song H, Shen J, Xu L, Li Y, Qu C, et al. Mfsd2a reverses spatial learning and memory impairment caused by chronic cerebral hypoperfusion via protection of the blood-brain barrier. Front Neurosci. 2020;14:461.","journal-title":"Front Neurosci"},{"key":"478_CR103","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2019.146379","volume":"1723","author":"J Shang","year":"2019","unstructured":"Shang J, Yamashita T, Tian F, Li X, Liu X, Shi X, et al. Chronic cerebral hypoperfusion alters amyloid-\u03b2 transport related proteins in the cortical blood vessels of Alzheimer\u2019s disease model mouse. Brain Res. 2019;1723: 146379.","journal-title":"Brain Res"},{"issue":"1","key":"478_CR104","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/joim.13263","volume":"292","author":"A Ben-Zvi","year":"2022","unstructured":"Ben-Zvi A, Liebner S. Developmental regulation of barrier- and non-barrier blood vessels in the CNS. J Intern Med. 2022;292(1):31\u201346.","journal-title":"J Intern Med"},{"issue":"4","key":"478_CR105","doi-asserted-by":"publisher","first-page":"a041219","DOI":"10.1101\/cshperspect.a041219","volume":"12","author":"ML Bats","year":"2022","unstructured":"Bats ML, Peghaire C, Delobel V, Dufourcq P, Couffinhal T, Duplaa C. Wnt\/frizzled signaling in endothelium: a major player in blood-retinal- and blood-brain-barrier integrity. Cold Spring Harb Perspect Med. 2022;12(4):a041219.","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"1","key":"478_CR106","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s13041-019-0525-5","volume":"12","author":"L Jia","year":"2019","unstructured":"Jia L, Pi\u00f1a-Crespo J, Li Y. Restoring Wnt\/\u03b2-catenin signaling is a promising therapeutic strategy for Alzheimer\u2019s disease. Mol Brain. 2019;12(1):104.","journal-title":"Mol Brain"},{"issue":"5905","key":"478_CR107","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1126\/science.1164594","volume":"322","author":"JM Stenman","year":"2008","unstructured":"Stenman JM, Rajagopal J, Carroll TJ, Ishibashi M, McMahon J, McMahon AP. Canonical Wnt signaling regulates organ-specific assembly and differentiation of CNS vasculature. Science. 2008;322(5905):1247\u201350.","journal-title":"Science"},{"key":"478_CR108","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2022.895429","volume":"15","author":"B Hussain","year":"2022","unstructured":"Hussain B, Fang C, Huang X, Feng Z, Yao Y, Wang Y, et al. Endothelial \u03b2-catenin deficiency causes blood-brain barrier breakdown via enhancing the paracellular and transcellular permeability. Front Mol Neurosci. 2022;15: 895429.","journal-title":"Front Mol Neurosci"},{"issue":"5","key":"478_CR109","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1038\/s41593-019-0369-4","volume":"22","author":"J Niu","year":"2019","unstructured":"Niu J, Tsai HH, Hoi KK, Huang N, Yu G, Kim K, et al. Aberrant oligodendroglial-vascular interactions disrupt the blood-brain barrier, triggering CNS inflammation. Nat Neurosci. 2019;22(5):709\u201318.","journal-title":"Nat Neurosci"},{"issue":"2","key":"478_CR110","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1007\/s12035-018-1103-z","volume":"56","author":"J Folke","year":"2019","unstructured":"Folke J, Pakkenberg B, Brudek T. Impaired Wnt signaling in the prefrontal cortex of Alzheimer\u2019s disease. Mol Neurobiol. 2019;56(2):873\u201391.","journal-title":"Mol Neurobiol"},{"key":"478_CR111","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.brainres.2011.08.044","volume":"1418","author":"KD Kania","year":"2011","unstructured":"Kania KD, Wijesuriya HC, Hladky SB, Barrand MA. Beta amyloid effects on expression of multidrug efflux transporters in brain endothelial cells. Brain Res. 2011;1418:1\u201311.","journal-title":"Brain Res"},{"issue":"2","key":"478_CR112","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1111\/j.1471-4159.2006.03867.x","volume":"98","author":"A Caruso","year":"2006","unstructured":"Caruso A, Motolese M, Iacovelli L, Caraci F, Copani A, Nicoletti F, et al. Inhibition of the canonical Wnt signaling pathway by apolipoprotein E4 in PC12 cells. J Neurochem. 2006;98(2):364\u201371.","journal-title":"J Neurochem"},{"issue":"6582","key":"478_CR113","doi-asserted-by":"publisher","first-page":"eabm4459","DOI":"10.1126\/science.abm4459","volume":"375","author":"M Martin","year":"2022","unstructured":"Martin M, Vermeiren S, Bostaille N, Eubelen M, Spitzer D, Vermeersch M, et al. Engineered Wnt ligands enable blood-brain barrier repair in neurological disorders. Science. 2022;375(6582):eabm4459.","journal-title":"Science"},{"issue":"1","key":"478_CR114","doi-asserted-by":"publisher","first-page":"2947","DOI":"10.1038\/s41467-023-37689-1","volume":"14","author":"J Ding","year":"2023","unstructured":"Ding J, Lee SJ, Vlahos L, Yuki K, Rada CC, van Unen V, et al. Therapeutic blood-brain barrier modulation and stroke treatment by a bioengineered FZD(4)-selective WNT surrogate in mice. Nat Commun. 2023;14(1):2947.","journal-title":"Nat Commun"},{"issue":"1","key":"478_CR115","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1038\/s41467-022-28785-9","volume":"13","author":"K Boye","year":"2022","unstructured":"Boye K, Geraldo LH, Furtado J, Pibouin-Fragner L, Poulet M, Kim D, et al. Endothelial Unc5B controls blood-brain barrier integrity. Nat Commun. 2022;13(1):1169.","journal-title":"Nat Commun"},{"issue":"35","key":"478_CR116","doi-asserted-by":"publisher","first-page":"eaba7457","DOI":"10.1126\/sciadv.aba7457","volume":"6","author":"Z Wang","year":"2020","unstructured":"Wang Z, Liu CH, Huang S, Fu Z, Tomita Y, Britton WR, et al. Wnt signaling activates MFSD2A to suppress vascular endothelial transcytosis and maintain blood-retinal barrier. Sci Adv. 2020;6(35):eaba7457.","journal-title":"Sci Adv"},{"issue":"2","key":"478_CR117","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1177\/0271678X17744124","volume":"38","author":"A Salehi","year":"2018","unstructured":"Salehi A, Jullienne A, Baghchechi M, Hamer M, Walsworth M, Donovan V, et al. Up-regulation of Wnt\/beta-catenin expression is accompanied with vascular repair after traumatic brain injury. J Cereb Blood Flow Metab. 2018;38(2):274\u201389.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"5","key":"478_CR118","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1089\/neu.2016.4871","volume":"35","author":"JY Zhang","year":"2018","unstructured":"Zhang JY, Lee JH, Gu X, Wei ZZ, Harris MJ, Yu SP, et al. Intranasally delivered Wnt3a improves functional recovery after traumatic brain injury by modulating autophagic, apoptotic, and regenerative pathways in the mouse brain. J Neurotrauma. 2018;35(5):802\u201313.","journal-title":"J Neurotrauma"},{"issue":"12","key":"478_CR119","doi-asserted-by":"publisher","first-page":"4474","DOI":"10.1093\/brain\/awac236","volume":"145","author":"Q Wang","year":"2022","unstructured":"Wang Q, Huang X, Su Y, Yin G, Wang S, Yu B, et al. Activation of Wnt\/beta-catenin pathway mitigates blood-brain barrier dysfunction in Alzheimer\u2019s disease. Brain. 2022;145(12):4474\u201388.","journal-title":"Brain"},{"issue":"4","key":"478_CR120","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1038\/s41419-024-06639-0","volume":"15","author":"X Huang","year":"2024","unstructured":"Huang X, Qi J, Su Y, Zhou Y, Wang Q, Huang T, et al. Endothelial DR6 in blood-brain barrier malfunction in Alzheimer\u2019s disease. Cell Death Dis. 2024;15(4):258.","journal-title":"Cell Death Dis"},{"issue":"3","key":"478_CR121","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1124\/pharmrev.121.000349","volume":"74","author":"LGN de Almeida","year":"2022","unstructured":"de Almeida LGN, Thode H, Eslambolchi Y, Chopra S, Young D, Gill S, et al. Matrix metalloproteinases: from molecular mechanisms to physiology, pathophysiology, and pharmacology. Pharmacol Rev. 2022;74(3):712\u201368.","journal-title":"Pharmacol Rev"},{"key":"478_CR122","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.neuropharm.2018.08.004","volume":"145","author":"RM Jha","year":"2019","unstructured":"Jha RM, Kochanek PM, Simard JM. Pathophysiology and treatment of cerebral edema in traumatic brain injury. Neuropharmacology. 2019;145:230\u201346.","journal-title":"Neuropharmacology"},{"key":"478_CR123","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuint.2023.105642","volume":"172","author":"A Sunny","year":"2024","unstructured":"Sunny A, James RR, Menon SR, Rayaroth S, Daniel A, Thompson NA, et al. Matrix Metalloproteinase-9 inhibitors as therapeutic drugs for traumatic brain injury. Neurochem Int. 2024;172: 105642.","journal-title":"Neurochem Int"},{"issue":"12","key":"478_CR124","doi-asserted-by":"publisher","first-page":"8296","DOI":"10.1007\/s12035-019-01672-z","volume":"56","author":"B Shackleton","year":"2019","unstructured":"Shackleton B, Ringland C, Abdullah L, Mullan M, Crawford F, Bachmeier C. Influence of matrix metallopeptidase 9 on beta-amyloid elimination across the blood-brain barrier. Mol Neurobiol. 2019;56(12):8296\u2013305.","journal-title":"Mol Neurobiol"},{"key":"478_CR125","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.bbrc.2021.09.044","volume":"579","author":"D Zou","year":"2021","unstructured":"Zou D, Hu W, Qin J, Wei Z, Wang D, Li L. Rapid orderly migration of neutrophils after traumatic brain injury depends on MMP9\/13. Biochem Biophys Res Commun. 2021;579:161\u20137.","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"478_CR126","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s11011-014-9550-3","volume":"30","author":"N Muradashvili","year":"2015","unstructured":"Muradashvili N, Benton RL, Saatman KE, Tyagi SC, Lominadze D. Ablation of matrix metalloproteinase-9 gene decreases cerebrovascular permeability and fibrinogen deposition post traumatic brain injury in mice. Metab Brain Dis. 2015;30(2):411\u201326.","journal-title":"Metab Brain Dis"},{"issue":"2","key":"478_CR127","doi-asserted-by":"publisher","first-page":"553","DOI":"10.3233\/JAD-200146","volume":"76","author":"M Hernandes-Alejandro","year":"2020","unstructured":"Hernandes-Alejandro M, Montano S, Harrington CR, Wischik CM, Salas-Casas A, Cortes-Reynosa P, et al. Analysis of the relationship between metalloprotease-9 and tau protein in Alzheimer\u2019s disease. J Alzheimers Dis. 2020;76(2):553\u201369.","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"478_CR128","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s12868-021-00643-2","volume":"22","author":"C Ringland","year":"2021","unstructured":"Ringland C, Schweig JE, Eisenbaum M, Paris D, Ait-Ghezala G, Mullan M, et al. MMP9 modulation improves specific neurobehavioral deficits in a mouse model of Alzheimer\u2019s disease. BMC Neurosci. 2021;22(1):39.","journal-title":"BMC Neurosci"},{"key":"478_CR129","doi-asserted-by":"publisher","first-page":"102271","DOI":"10.1016\/j.arr.2024.102271","volume":"96","author":"A Parashar","year":"2024","unstructured":"Parashar A, Jha D, Mehta V, Chauhan B, Ghosh P, Deb PK, et al. Sonic hedgehog signalling pathway contributes in age-related disorders and Alzheimer\u2019s disease. Ageing Res Rev. 2024;96:102271.","journal-title":"Ageing Res Rev"},{"issue":"6063","key":"478_CR130","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1126\/science.1206936","volume":"334","author":"JI Alvarez","year":"2011","unstructured":"Alvarez JI, Dodelet-Devillers A, Kebir H, Ifergan I, Fabre PJ, Terouz S, et al. The Hedgehog pathway promotes blood-brain barrier integrity and CNS immune quiescence. Science. 2011;334(6063):1727\u201331.","journal-title":"Science"},{"issue":"4","key":"478_CR131","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1007\/s12975-019-00771-2","volume":"11","author":"J Wu","year":"2020","unstructured":"Wu J, He J, Tian X, Zhong J, Li H, Sun X. Activation of the hedgehog pathway promotes recovery of neurological function after traumatic brain injury by protecting the neurovascular unit. Transl Stroke Res. 2020;11(4):720\u201333.","journal-title":"Transl Stroke Res"},{"issue":"1","key":"478_CR132","doi-asserted-by":"publisher","first-page":"32","DOI":"10.3390\/biomedicines10010032","volume":"10","author":"J Hentig","year":"2021","unstructured":"Hentig J, Campbell LJ, Cloghessy K, Lee M, Boggess W, Hyde DR. Prophylactic activation of shh signaling attenuates TBI-induced seizures in zebrafish by modulating glutamate excitotoxicity through Eaat2a. Biomedicines. 2021;10(1):32.","journal-title":"Biomedicines"},{"issue":"1","key":"478_CR133","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1089\/neur.2020.0016","volume":"2","author":"AK Pringle","year":"2021","unstructured":"Pringle AK, Solomon E, Coles BJ, Desousa BR, Shtaya A, Gajavelli S, et al. Sonic hedgehog signaling promotes peri-lesion cell proliferation and functional improvement after cortical contusion injury. Neurotrauma Rep. 2021;2(1):27\u201338.","journal-title":"Neurotrauma Rep"},{"key":"478_CR134","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuint.2021.105042","volume":"146","author":"S Michinaga","year":"2021","unstructured":"Michinaga S, Inoue A, Sonoda K, Mizuguchi H, Koyama Y. Down-regulation of astrocytic sonic hedgehog by activation of endothelin ETB receptors: Involvement in traumatic brain injury-induced disruption of blood brain barrier in a mouse model. Neurochem Int. 2021;146: 105042.","journal-title":"Neurochem Int"},{"key":"478_CR135","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13630-018-0059-y","volume":"7","author":"AG Vorobyeva","year":"2018","unstructured":"Vorobyeva AG, Saunders AJ. Amyloid-\u03b2 interrupts canonical Sonic hedgehog signaling by distorting primary cilia structure. Cilia. 2018;7:5.","journal-title":"Cilia"},{"issue":"11","key":"478_CR136","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1080\/00207454.2020.1773821","volume":"131","author":"XL Li","year":"2021","unstructured":"Li XL, Wang P, Xie Y. Protease nexin-1 protects against Alzheimer\u2019s disease by regulating the sonic hedgehog signaling pathway. Int J Neurosci. 2021;131(11):1087\u201396.","journal-title":"Int J Neurosci"},{"issue":"34","key":"478_CR137","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2017779118","volume":"118","author":"H Wang","year":"2021","unstructured":"Wang H, Xu Z, Xia Z, Rallo M, Duffy A, Matise MP. Inactivation of Hedgehog signal transduction in adult astrocytes results in region-specific blood\u2013brain barrier defects. Proc Natl Acad Sci USA. 2021;118(34): e2017779118.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"478_CR138","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/j.cell.2017.02.004","volume":"168","author":"RA Saxton","year":"2017","unstructured":"Saxton RA, Sabatini DM. mTOr signaling in growth, metabolism, and disease. Cell. 2017;168(6):960\u201376.","journal-title":"Cell"},{"issue":"6","key":"478_CR139","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1038\/s43587-023-00416-y","volume":"3","author":"JB Mannick","year":"2023","unstructured":"Mannick JB, Lamming DW. Targeting the biology of aging with mTOR inhibitors. Nature Aging. 2023;3(6):642\u201360.","journal-title":"Nature Aging"},{"key":"478_CR140","doi-asserted-by":"publisher","first-page":"1005631","DOI":"10.3389\/fnmol.2022.1005631","volume":"15","author":"M Girodengo","year":"2022","unstructured":"Girodengo M, Ultanir SK, Bateman JM. Mechanistic target of rapamycin signaling in human nervous system development and disease. Front Mol Neurosci. 2022;15:1005631.","journal-title":"Front Mol Neurosci"},{"key":"478_CR141","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuint.2022.105311","volume":"155","author":"D Rapaka","year":"2022","unstructured":"Rapaka D, Bitra VR, Challa SR, Adiukwu PC. mTOR signaling as a molecular target for the alleviation of Alzheimer\u2019s disease pathogenesis. Neurochem Int. 2022;155: 105311.","journal-title":"Neurochem Int"},{"key":"478_CR142","doi-asserted-by":"publisher","first-page":"1366061","DOI":"10.3389\/fphar.2024.1366061","volume":"15","author":"PL Xie","year":"2024","unstructured":"Xie PL, Zheng MY, Han R, Chen WX, Mao JH. Pharmacological mTOR inhibitors in ameliorating Alzheimer\u2019s disease: current review and perspectives. Front Pharmacol. 2024;15:1366061.","journal-title":"Front Pharmacol"},{"issue":"9","key":"478_CR143","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1002\/iub.2324","volume":"72","author":"MS Uddin","year":"2020","unstructured":"Uddin MS, Rahman MA, Kabir MT, Behl T, Mathew B, Perveen A, et al. Multifarious roles of mTOR signaling in cognitive aging and cerebrovascular dysfunction of Alzheimer\u2019s disease. IUBMB Life. 2020;72(9):1843\u201355.","journal-title":"IUBMB Life"},{"issue":"4","key":"478_CR144","doi-asserted-by":"publisher","first-page":"H693","DOI":"10.1152\/ajpheart.00570.2017","volume":"314","author":"CE Van Skike","year":"2018","unstructured":"Van Skike CE, Jahrling JB, Olson AB, Sayre NL, Hussong SA, Ungvari Z, et al. Inhibition of mTOR protects the blood-brain barrier in models of Alzheimer\u2019s disease and vascular cognitive impairment. Am J Physiol Heart Circ Physiol. 2018;314(4):H693-h703.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"19","key":"478_CR145","doi-asserted-by":"publisher","first-page":"4305","DOI":"10.1523\/JNEUROSCI.2144-20.2021","volume":"41","author":"CE Van Skike","year":"2021","unstructured":"Van Skike CE, Hussong SA, Hernandez SF, Banh AQ, DeRosa N, Galvan V. mTOR attenuation with rapamycin reverses neurovascular uncoupling and memory deficits in mice modeling Alzheimer\u2019s disease. J Neurosci. 2021;41(19):4305\u201320.","journal-title":"J Neurosci"},{"issue":"7","key":"478_CR146","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1111\/cns.14133","volume":"29","author":"G Jiang","year":"2023","unstructured":"Jiang G, Long Z, Wang Y, Wang Y, Xue P, Chen M, et al. Inhibition of mammalian target of rapamycin complex 1 in the brain microvascular endothelium ameliorates diabetic A\u03b2 brain deposition and cognitive impairment via the sterol-regulatory element-binding protein 1\/lipoprotein receptor-associated protein 1 signaling pathway. CNS Neurosci Ther. 2023;29(7):1762\u201375.","journal-title":"CNS Neurosci Ther"},{"issue":"1","key":"478_CR147","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1177\/0271678X15621575","volume":"37","author":"AL Lin","year":"2017","unstructured":"Lin AL, Jahrling JB, Zhang W, DeRosa N, Bakshi V, Romero P, et al. Rapamycin rescues vascular, metabolic and learning deficits in apolipoprotein E4 transgenic mice with pre-symptomatic Alzheimer\u2019s disease. J Cereb Blood Flow Metab. 2017;37(1):217\u201326.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"5","key":"478_CR148","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1038\/sj.jcbfm.9600393","volume":"27","author":"S Chen","year":"2007","unstructured":"Chen S, Atkins CM, Liu CL, Alonso OF, Dietrich WD, Hu BR. Alterations in mammalian target of rapamycin signaling pathways after traumatic brain injury. J Cereb Blood Flow Metab. 2007;27(5):939\u201349.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"2","key":"478_CR149","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1089\/neu.2014.3469","volume":"32","author":"NS Rozas","year":"2015","unstructured":"Rozas NS, Redell JB, Hill JL, McKenna J 3rd, Moore AN, Gambello MJ, et al. Genetic activation of mTORC1 signaling worsens neurocognitive outcome after traumatic brain injury. J Neurotrauma. 2015;32(2):149\u201358.","journal-title":"J Neurotrauma"},{"issue":"3","key":"478_CR150","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1002\/cbf.3692","volume":"40","author":"A Movahedpour","year":"2022","unstructured":"Movahedpour A, Vakili O, Khalifeh M, Mousavi P, Mahmoodzadeh A, Taheri-Anganeh M, et al. Mammalian target of rapamycin (mTOR) signaling pathway and traumatic brain injury: a novel insight into targeted therapy. Cell Biochem Funct. 2022;40(3):232\u201347.","journal-title":"Cell Biochem Funct"},{"issue":"2","key":"478_CR151","doi-asserted-by":"publisher","DOI":"10.1111\/acel.14040","volume":"23","author":"MT Islam","year":"2024","unstructured":"Islam MT, Hall SA, Dutson T, Bloom SI, Bramwell RC, Kim J, et al. Endothelial cell-specific reduction in mTOR ameliorates age-related arterial and metabolic dysfunction. Aging Cell. 2024;23(2): e14040.","journal-title":"Aging Cell"},{"key":"478_CR152","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20191212","author":"P Ramalingam","year":"2020","unstructured":"Ramalingam P, Poulos MG, Gutkin MC, Katsnelson L, Freire AG, Lazzari E, et al. Endothelial mTOR maintains hematopoiesis during aging. J Exp Med.\u00a02020;217(6):e20191212.","journal-title":"J Exp Med"},{"issue":"1","key":"478_CR153","doi-asserted-by":"publisher","first-page":"4407","DOI":"10.1038\/s41467-021-24567-x","volume":"12","author":"Y Ehinger","year":"2021","unstructured":"Ehinger Y, Zhang Z, Phamluong K, Soneja D, Shokat KM, Ron D. Brain-specific inhibition of mTORC1 eliminates side effects resulting from mTORC1 blockade in the periphery and reduces alcohol intake in mice. Nat Commun. 2021;12(1):4407.","journal-title":"Nat Commun"},{"issue":"7928","key":"478_CR154","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1038\/s41586-022-05213-y","volume":"609","author":"Z Zhang","year":"2022","unstructured":"Zhang Z, Fan Q, Luo X, Lou K, Weiss WA, Shokat KM. Brain-restricted mTOR inhibition with binary pharmacology. Nature. 2022;609(7928):822\u20138.","journal-title":"Nature"},{"issue":"5","key":"478_CR155","doi-asserted-by":"publisher","DOI":"10.1523\/ENEURO.0162-16.2016","volume":"3","author":"X Wang","year":"2016","unstructured":"Wang X, Seekaew P, Gao X, Chen J. Traumatic brain injury stimulates neural stem cell proliferation via mammalian target of rapamycin signaling pathway activation. eNeuro.\u00a02016;3(5):ENEURO.0162-16.2016.","journal-title":"eNeuro"},{"key":"478_CR156","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.neulet.2016.03.053","volume":"620","author":"OZ Chi","year":"2016","unstructured":"Chi OZ, Mellender SJ, Barsoum S, Liu X, Damito S, Weiss HR. Effects of rapamycin pretreatment on blood-brain barrier disruption in cerebral ischemia-reperfusion. Neurosci Lett. 2016;620:132\u20136.","journal-title":"Neurosci Lett"},{"issue":"5302","key":"478_CR157","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1126\/science.275.5302.964","volume":"275","author":"T Asahara","year":"1997","unstructured":"Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, et al. Isolation of Putative progenitor endothelial cells for angiogenesis. Science. 1997;275(5302):964\u20136.","journal-title":"Science"},{"key":"478_CR158","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2021.811210","volume":"13","author":"A Custodia","year":"2021","unstructured":"Custodia A, Ouro A, Romaus-Sanjurjo D, P\u00edas-Peleteiro JM, de Vries HE, Castillo J, et al. Endothelial progenitor cells and vascular alterations in Alzheimer\u2019s disease. Front Aging Neurosci. 2021;13: 811210.","journal-title":"Front Aging Neurosci"},{"issue":"1","key":"478_CR159","doi-asserted-by":"publisher","first-page":"115","DOI":"10.14336\/AD.2016.0610","volume":"8","author":"Y Lin","year":"2017","unstructured":"Lin Y, Luo LL, Sun J, Gao W, Tian Y, Park E, et al. Relationship of circulating CXCR4(+) EPC with prognosis of mild traumatic brain injury patients. Aging Dis. 2017;8(1):115\u201327.","journal-title":"Aging Dis"},{"issue":"24","key":"478_CR160","doi-asserted-by":"publisher","first-page":"2080","DOI":"10.1089\/neu.2013.2996","volume":"30","author":"XT Huang","year":"2013","unstructured":"Huang XT, Zhang YQ, Li SJ, Li SH, Tang Q, Wang ZT, et al. Intracerebroventricular transplantation of ex vivo expanded endothelial colony-forming cells restores blood-brain barrier integrity and promotes angiogenesis of mice with traumatic brain injury. J Neurotrauma. 2013;30(24):2080\u20138.","journal-title":"J Neurotrauma"},{"key":"478_CR161","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.jns.2018.01.019","volume":"387","author":"S Zhang","year":"2018","unstructured":"Zhang S, Zhi Y, Li F, Huang S, Gao H, Han Z, et al. Transplantation of in vitro cultured endothelial progenitor cells repairs the blood-brain barrier and improves cognitive function of APP\/PS1 transgenic AD mice. J Neurol Sci. 2018;387:6\u201315.","journal-title":"J Neurol Sci"},{"key":"478_CR162","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.expneurol.2018.06.001","volume":"307","author":"W Gao","year":"2018","unstructured":"Gao W, Li F, Liu L, Xu X, Zhang B, Wu Y, et al. Endothelial colony-forming cell-derived exosomes restore blood-brain barrier continuity in mice subjected to traumatic brain injury. Exp Neurol. 2018;307:99\u2013108.","journal-title":"Exp Neurol"},{"issue":"3","key":"478_CR163","doi-asserted-by":"publisher","first-page":"299","DOI":"10.2174\/1574888X17666220511153133","volume":"18","author":"MA Jim\u00e9nez-Acosta","year":"2023","unstructured":"Jim\u00e9nez-Acosta MA, Hern\u00e1ndez LJR, Cristerna MLP, Meraz-R\u00edos MA. Mesenchymal stem cells: new alternatives for nervous system disorders. Curr Stem Cell Res Ther. 2023;18(3):299\u2013321.","journal-title":"Curr Stem Cell Res Ther"},{"issue":"161","key":"478_CR164","doi-asserted-by":"publisher","first-page":"161ra50","DOI":"10.1126\/scitranslmed.3004660","volume":"4","author":"T Menge","year":"2012","unstructured":"Menge T, Zhao Y, Zhao J, Wataha K, Gerber M, Zhang J, et al. Mesenchymal stem cells regulate blood-brain barrier integrity through TIMP3 release after traumatic brain injury. Sci Transl Med. 2012;4(161):161ra50.","journal-title":"Sci Transl Med"},{"issue":"12","key":"478_CR165","doi-asserted-by":"publisher","first-page":"3530","DOI":"10.1002\/stem.2189","volume":"33","author":"SL Gibb","year":"2015","unstructured":"Gibb SL, Zhao Y, Potter D, Hylin MJ, Bruhn R, Baimukanova G, et al. TIMP3 attenuates the loss of neural stem cells, mature neurons and neurocognitive dysfunction in traumatic brain injury. Stem cells. 2015;33(12):3530\u201344.","journal-title":"Stem cells"},{"issue":"8","key":"478_CR166","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.112956","volume":"42","author":"P Mishra","year":"2023","unstructured":"Mishra P, Silva A, Sharma J, Nguyen J, Pizzo DP, Hinz D, et al. Rescue of Alzheimer\u2019s disease phenotype in a mouse model by transplantation of wild-type hematopoietic stem and progenitor cells. Cell Rep. 2023;42(8): 112956.","journal-title":"Cell Rep"},{"key":"478_CR167","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/978-3-030-31206-0_4","volume":"1201","author":"JP Tuazon","year":"2019","unstructured":"Tuazon JP, Castelli V, Lee JY, Desideri GB, Stuppia L, Cimini AM, et al. Neural stem cells. Adv Exp Med Biol. 2019;1201:79\u201391.","journal-title":"Adv Exp Med Biol"},{"issue":"1","key":"478_CR168","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00441-017-2738-1","volume":"371","author":"X Zhao","year":"2018","unstructured":"Zhao X, Moore DL. Neural stem cells: developmental mechanisms and disease modeling. Cell Tissue Res. 2018;371(1):1\u20136.","journal-title":"Cell Tissue Res"},{"key":"478_CR169","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2021.650103","volume":"13","author":"MH Lu","year":"2021","unstructured":"Lu MH, Ji WL, Chen H, Sun YY, Zhao XY, Wang F, et al. Intranasal transplantation of human neural stem cells ameliorates Alzheimer\u2019s disease-like pathology in a mouse model. Front Aging Neurosci. 2021;13: 650103.","journal-title":"Front Aging Neurosci"},{"issue":"1","key":"478_CR170","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/s13287-018-0913-2","volume":"9","author":"AC Boese","year":"2018","unstructured":"Boese AC, Le QE, Pham D, Hamblin MH, Lee JP. Neural stem cell therapy for subacute and chronic ischemic stroke. Stem Cell Res Ther. 2018;9(1):154.","journal-title":"Stem Cell Res Ther"},{"issue":"7","key":"478_CR171","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.3390\/cells10071802","volume":"10","author":"E Armijo","year":"2021","unstructured":"Armijo E, Edwards G, Flores A, Vera J, Shahnawaz M, Moda F, et al. Induced pluripotent stem cell-derived neural precursors improve memory, synaptic and pathological abnormalities in a mouse model of Alzheimer\u2019s disease. Cells. 2021;10(7):1802.","journal-title":"Cells"},{"issue":"6","key":"478_CR172","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1093\/stmcls\/sxad028","volume":"41","author":"R Imai","year":"2023","unstructured":"Imai R, Tamura R, Yo M, Sato M, Fukumura M, Takahara K, et al. Neuroprotective effects of genome-edited human ips cell-derived neural stem\/progenitor cells on traumatic brain injury. Stem Cell. 2023;41(6):603\u201316.","journal-title":"Stem Cell"},{"issue":"7","key":"478_CR173","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1016\/j.jcyt.2018.03.036","volume":"20","author":"E Hoveizi","year":"2018","unstructured":"Hoveizi E, Mohammadi T, Moazedi AA, Zamani N, Eskandary A. Transplanted neural-like cells improve memory and Alzheimer-like pathology in a rat model. Cytotherapy. 2018;20(7):964\u201373.","journal-title":"Cytotherapy"},{"key":"478_CR174","doi-asserted-by":"publisher","first-page":"895","DOI":"10.3389\/fneur.2018.00895","volume":"9","author":"M Nasser","year":"2018","unstructured":"Nasser M, Ballout N, Mantash S, Bejjani F, Najdi F, Ramadan N, et al. Transplantation of embryonic neural stem cells and differentiated cells in a controlled cortical impact (CCI) model of adult mouse somatosensory cortex. Front Neurol. 2018;9:895.","journal-title":"Front Neurol"},{"key":"478_CR175","doi-asserted-by":"publisher","first-page":"1102809","DOI":"10.3389\/fnagi.2023.1102809","volume":"15","author":"JA Sousa","year":"2023","unstructured":"Sousa JA, Bernardes C, Bernardo-Castro S, Lino M, Albino I, Ferreira L, et al. Reconsidering the role of blood-brain barrier in Alzheimer\u2019s disease: From delivery to target. Front Aging Neurosci. 2023;15:1102809.","journal-title":"Front Aging Neurosci"},{"issue":"4","key":"478_CR176","doi-asserted-by":"publisher","first-page":"e20190062","DOI":"10.1084\/jem.20190062","volume":"217","author":"CP Profaci","year":"2020","unstructured":"Profaci CP, Munji RN, Pulido RS, Daneman R. The blood-brain barrier in health and disease: Important unanswered questions. J Exp Med.\u00a02020;217(4):e20190062.","journal-title":"J Exp Med"},{"issue":"7816","key":"478_CR177","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/s41586-020-2453-z","volume":"583","author":"AC Yang","year":"2020","unstructured":"Yang AC, Stevens MY, Chen MB, Lee DP, Stahli D, Gate D, et al. Physiological blood-brain transport is impaired with age by a shift in transcytosis. Nature. 2020;583(7816):425\u201330.","journal-title":"Nature"},{"issue":"8013","key":"478_CR178","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1038\/s41586-024-07314-2","volume":"629","author":"C Wei","year":"2024","unstructured":"Wei C, Jiang W, Wang R, Zhong H, He H, Gao X, et al. Brain endothelial GSDMD activation mediates inflammatory BBB breakdown. Nature. 2024;629(8013):893\u2013900.","journal-title":"Nature"},{"issue":"23","key":"478_CR179","doi-asserted-by":"publisher","first-page":"3204","DOI":"10.1089\/neu.2021.0094","volume":"38","author":"DH Smith","year":"2021","unstructured":"Smith DH, Kochanek PM, Rosi S, Meyer R, Ferland-Beckham C, Prager EM, et al. Roadmap for advancing pre-clinical science in traumatic brain injury. J Neurotrauma. 2021;38(23):3204\u201321.","journal-title":"J Neurotrauma"},{"issue":"11","key":"478_CR180","doi-asserted-by":"publisher","first-page":"6222","DOI":"10.3390\/ijms25116222","volume":"25","author":"HM Collins","year":"2024","unstructured":"Collins HM, Greenfield S. Rodent models of Alzheimer\u2019s disease: past misconceptions and future prospects. Int J Mol Sci. 2024;25(11):6222.","journal-title":"Int J Mol Sci"},{"issue":"7","key":"478_CR181","doi-asserted-by":"publisher","first-page":"5035","DOI":"10.1002\/alz.13742","volume":"20","author":"M Sasner","year":"2024","unstructured":"Sasner M, Onos KD, Territo PR, Sukoff Rizzo SJ. Meeting report of the fifth annual workshop on principles and techniques for improving preclinical to clinical translation in Alzheimer\u2019s Disease research. Alzheimers Dement. 2024;20(7):5035\u201343.","journal-title":"Alzheimers Dement"},{"key":"478_CR182","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2022.807473","volume":"16","author":"H Sasaguri","year":"2022","unstructured":"Sasaguri H, Hashimoto S, Watamura N, Sato K, Takamura R, Nagata K, et al. Recent advances in the modeling of Alzheimer\u2019s Disease. Front Neurosci. 2022;16: 807473.","journal-title":"Front Neurosci"},{"key":"478_CR183","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2020.105059","volume":"145","author":"M Chiasseu","year":"2020","unstructured":"Chiasseu M, Fesharaki-Zadeh A, Saito T, Saido TC, Strittmatter SM. Gene-environment interaction promotes Alzheimer\u2019s risk as revealed by synergy of repeated mild traumatic brain injury and mouse App knock-in. Neurobiol Dis. 2020;145: 105059.","journal-title":"Neurobiol Dis"},{"issue":"6","key":"478_CR184","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1056\/NEJMra1806175","volume":"380","author":"M Li","year":"2019","unstructured":"Li M, Belmonte JCI. Organoids \u2014 preclinical models of human disease. N Engl J Med. 2019;380(6):569\u201379.","journal-title":"N Engl J Med"},{"issue":"8","key":"478_CR185","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.molmed.2023.05.007","volume":"29","author":"J Cerneckis","year":"2023","unstructured":"Cerneckis J, Bu G, Shi Y. Pushing the boundaries of brain organoids to study Alzheimer\u2019s disease. Trends Mol Med. 2023;29(8):659\u201372.","journal-title":"Trends Mol Med"},{"key":"478_CR186","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2024.102517","volume":"102","author":"T Lei","year":"2024","unstructured":"Lei T, Zhang X, Fu G, Luo S, Zhao Z, Deng S, et al. Advances in human cellular mechanistic understanding and drug discovery of brain organoids for neurodegenerative diseases. Ageing Res Rev. 2024;102: 102517.","journal-title":"Ageing Res Rev"},{"issue":"6","key":"478_CR187","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1016\/j.stem.2024.04.019","volume":"31","author":"L Dao","year":"2024","unstructured":"Dao L, You Z, Lu L, Xu T, Sarkar AK, Zhu H, et al. Modeling blood-brain barrier formation and cerebral cavernous malformations in human PSC-derived organoids. Cell Stem Cell. 2024;31(6):818-33.e11.","journal-title":"Cell Stem Cell"},{"key":"478_CR188","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.cobme.2020.05.004","volume":"14","author":"D Jgamadze","year":"2020","unstructured":"Jgamadze D, Johnson VE, Wolf JA, Cullen DK, Song H, Ming GL, et al. Modeling traumatic brain injury with human brain organoids. Curr Opin Biomed Eng. 2020;14:52\u20138.","journal-title":"Curr Opin Biomed Eng"},{"issue":"1","key":"478_CR189","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/s40478-024-01845-5","volume":"12","author":"C Bellotti","year":"2024","unstructured":"Bellotti C, Samudyata S, Thams S, Sellgren CM, Rostami E. Organoids and chimeras: the hopeful fusion transforming traumatic brain injury research. Acta Neuropathol Commun. 2024;12(1):141.","journal-title":"Acta Neuropathol Commun"},{"issue":"1","key":"478_CR190","doi-asserted-by":"publisher","DOI":"10.1080\/21688370.2016.1143544","volume":"4","author":"I Wilhelm","year":"2016","unstructured":"Wilhelm I, Ny\u00fal-T\u00f3th \u00c1, Suciu M, Hermenean A, Krizbai IA. Heterogeneity of the blood-brain barrier. Tissue Barriers. 2016;4(1): e1143544.","journal-title":"Tissue Barriers"},{"issue":"4","key":"478_CR191","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.3390\/ijms25041991","volume":"25","author":"TL Davidson","year":"2024","unstructured":"Davidson TL, Stevenson RJ. Vulnerability of the hippocampus to insults: links to blood-brain barrier dysfunction. Int J Mol Sci. 2024;25(4):1991.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"478_CR192","doi-asserted-by":"publisher","first-page":"11344","DOI":"10.1038\/s41598-018-29341-6","volume":"8","author":"AF Logsdon","year":"2018","unstructured":"Logsdon AF, Meabon JS, Cline MM, Bullock KM, Raskind MA, Peskind ER, et al. Blast exposure elicits blood-brain barrier disruption and repair mediated by tight junction integrity and nitric oxide dependent processes. Sci Rep. 2018;8(1):11344.","journal-title":"Sci Rep"},{"issue":"1","key":"478_CR193","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/ejn.14547","volume":"53","author":"KA Dudek","year":"2021","unstructured":"Dudek KA, Dion-Albert L, Kaufmann FN, Tuck E, Lebel M, Menard C. Neurobiology of resilience in depression: immune and vascular insights from human and animal studies. Eur J Neurosci. 2021;53(1):183\u2013221.","journal-title":"Eur J Neurosci"},{"issue":"2","key":"478_CR194","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1093\/brain\/awz408","volume":"143","author":"M Wiesmann","year":"2020","unstructured":"Wiesmann M, de Leeuw FE. Vascular reserve in brain resilience: pipes or perfusion? Brain. 2020;143(2):390\u20132.","journal-title":"Brain"},{"issue":"2","key":"478_CR195","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s13311-020-00832-7","volume":"17","author":"NS Singhal","year":"2020","unstructured":"Singhal NS, Sun C-H, Lee EM, Ma DK. Resilience to injury: a new approach to neuroprotection? Neurotherapeutics. 2020;17(2):457\u201374.","journal-title":"Neurotherapeutics"},{"issue":"1","key":"478_CR196","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s13024-024-00719-7","volume":"19","author":"LE de Vries","year":"2024","unstructured":"de Vries LE, Huitinga I, Kessels HW, Swaab DF, Verhaagen J. The concept of resilience to Alzheimer\u2019s Disease: current definitions and cellular and molecular mechanisms. Mol Neurodegen. 2024;19(1):33.","journal-title":"Mol Neurodegen"},{"issue":"2","key":"478_CR197","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1093\/brain\/awz383","volume":"143","author":"V Perosa","year":"2020","unstructured":"Perosa V, Priester A, Ziegler G, Cardenas-Blanco A, Dobisch L, Spallazzi M, et al. Hippocampal vascular reserve associated with cognitive performance and hippocampal volume. Brain. 2020;143(2):622\u201334.","journal-title":"Brain"},{"issue":"6","key":"478_CR198","doi-asserted-by":"publisher","first-page":"3326","DOI":"10.1073\/pnas.1914655117","volume":"117","author":"KA Dudek","year":"2020","unstructured":"Dudek KA, Dion-Albert L, Lebel M, LeClair K, Labrecque S, Tuck E, et al. Molecular adaptations of the blood-brain barrier promote stress resilience vs. depression. Proc Natl Acad Sci USA. 2020;117(6):3326\u201336.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"478_CR199","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1038\/s41467-021-27604-x","volume":"13","author":"L Dion-Albert","year":"2022","unstructured":"Dion-Albert L, Cadoret A, Doney E, Kaufmann FN, Dudek KA, Daigle B, et al. Vascular and blood-brain barrier-related changes underlie stress responses and resilience in female mice and depression in human tissue. Nat Commun. 2022;13(1):164.","journal-title":"Nat Commun"},{"issue":"1","key":"478_CR200","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s40478-022-01395-8","volume":"10","author":"WB Hubbard","year":"2022","unstructured":"Hubbard WB, Velmurugan GV, Brown EP, Sullivan PG. Resilience of females to acute blood-brain barrier damage and anxiety behavior following mild blast traumatic brain injury. Acta Neuropathol Commun. 2022;10(1):93.","journal-title":"Acta Neuropathol Commun"}],"container-title":["Translational Neurodegeneration"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40035-025-00478-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40035-025-00478-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40035-025-00478-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,30]],"date-time":"2025-03-30T02:00:57Z","timestamp":1743300057000},"score":1,"resource":{"primary":{"URL":"https:\/\/translationalneurodegeneration.biomedcentral.com\/articles\/10.1186\/s40035-025-00478-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,26]]},"references-count":200,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["478"],"URL":"https:\/\/doi.org\/10.1186\/s40035-025-00478-5","relation":{},"ISSN":["2047-9158"],"issn-type":[{"value":"2047-9158","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,26]]},"assertion":[{"value":"11 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16"}}